angiotensin ii has been researched along with Rhabdomyosarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elizondo, FG; Sung, C | 1 |
| Bunko, H; Morikawa, S; Morishita, H; Ohno, M; Seto, M; Shimizu, H; Sugihara, M; Tomita, K; Tsuchiya, H; Yasutake, H | 1 |
2 other study(ies) available for angiotensin ii and Rhabdomyosarcoma
| Article | Year |
|---|---|
Effect of angiotensin II on immunotoxin uptake in tumor and normal tissue.
Topics: Angiotensin II; Animals; Autoradiography; Blood Pressure; Female; Humans; Hypertension; Immunotoxins; Infusions, Parenteral; Injections, Intravenous; Mice; Mice, Nude; Photoplethysmography; Rhabdomyosarcoma; Tissue Distribution; Vasoconstrictor Agents | 1996 |
[Angiotensin II-induced hypertension chemotherapy of bone and soft-tissue sarcomas].
Topics: Adolescent; Adult; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Bone Neoplasms; Child; Female; Histiocytoma, Benign Fibrous; Humans; Male; Middle Aged; Neurilemmoma; Osteosarcoma; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Sarcoma, Synovial; Soft Tissue Neoplasms | 1989 |